Russell Investments Group
IMCR icon

Russell Investments Group’s Immunocore IMCR Stock Holding History

Russell Investments Group’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$953 Hold
30
– – ﹤0.01% 4163
2026
Q1 		$905 Hold
30
– – ﹤0.01% 4077
2025
Q4 		$1.04K Hold
30
– – ﹤0.01% 4045
2025
Q3 		$1.09K Hold
30
– – ﹤0.01% 4045
2025
Q2 		$941 Hold
30
– – ﹤0.01% 3674
2025
Q1 		$890 Hold
30
– – ﹤0.01% 3604
2024
Q4 		$885 Hold
30
– – ﹤0.01% 3543
2024
Q3 		$934 Hold
30
– – ﹤0.01% 3494
2024
Q2 		$1.02K Sell
30
-41
-58% -$2.09K ﹤0.01% 3430
2024
Q1 		$4.62K Buy
71
+41
+137% +$2.81K ﹤0.01% 2956
2023
Q4 		$2.05K Hold
30
– – ﹤0.01% 3007
2023
Q3 		$1.56K Sell
30
-12
-29% -$710 ﹤0.01% 3293
2023
Q2 		$2.52K Buy
+42
New +$2.4K ﹤0.01% 3205

Other funds holding IMCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Russell Investments Group's IMCR Position: Q2 2026 in Review

Russell Investments Group held its Immunocore (IMCR) position steady in Q2 2026 at 30 shares worth $953. The position accounts for ﹤0.01% of the portfolio, ranked #4163.

Russell Investments Group first reported a position in IMCR in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.62K in Q1 2024. 40 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Russell Investments Group held 30 shares of Immunocore worth $953 as of Q2 2026.
  • Russell Investments Group left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4163 holding.
  • Russell Investments Group first reported a position in Immunocore in Q2 2023 and has held it in 13 quarters since.
  • Russell Investments Group's Immunocore position peaked at $4.62K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.